glp 1 agonist retatrutide 10mg & 20mg Research Peptide Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide
Description
After systemic administration, they engage both GLP1R and GIPR simultaneously in native tissue, enabling the study of receptor engagement, metabolic responses, and therapeutic effects at the cellular and organ level, going beyond localization to provide functional readouts directly in living models
doi: 10.1016/j.diabres.2012.10.017
Despite a significant improvement in the treatment of T2D and CVD over the past few decades, reducing CVD in patients with T2D solely with an optimal glycemic control has been challenging [2]
The difference between patients who took Rezdiffra was just 12%
Interestingly, while tirzepatide acts as an agonist of the GLP-1 receptor, it may effectively act as a GIP receptor antagonist
2 By affecting this process, GLP-1 is considered to be an enterogastronea hormone secreted when sugars or fatty foods enter the small intestine
